Compile Data Set for Download or QSAR
Report error Found 273 Enz. Inhib. hit(s) with all data for entry = 12838
TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732717((R)-N-ethyl-5-fluoro-N-(2,2,2-trifluoro-1-(4- fluo...)
Affinity DataIC50: 11.7nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732675((R)-N-ethyl-5-fluoro-N-(2,2,2-trifluoro-1-(4- fluo...)
Affinity DataIC50: 11.7nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732492((R)-5-cyano-N-ethyl-N-(2,2,2-trifluoro-1-(4- fluor...)
Affinity DataIC50: 13.5nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732602((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-fluorophenyl)e...)
Affinity DataIC50: 17.4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732643((R)-N-(1-(4-chlorophenyl)-2,2,2- trifluoroethyl)-N...)
Affinity DataIC50: 19.1nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732590((R)-N-(1-(4-chlorophenyl)-2,2,2- trifluoroethyl)-N...)
Affinity DataIC50: 22.4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732713((R)-N-ethyl-5-fluoro-N-(2,2,2-trifluoro-1-(4- meth...)
Affinity DataIC50: 22.9nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732568((R)-5-Cyano-N-ethyl-N-(2,2,2-trifluoro-1-(3- fluor...)
Affinity DataIC50: 23.4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732601((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-fluorophenyl)e...)
Affinity DataIC50: 25.1nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732627((R)—N-(1-(4-chlorophenyl)-2,2,2-trifluoroethyl)-5-...)
Affinity DataIC50: 25.7nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732683((R)—N-(1-(4-chlorophenyl)-2,2,2-trifluoroethyl)-5-...)
Affinity DataIC50: 28.2nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732718((R)-N-(1-(4-chlorophenyl)-2,2,2- trifluoroethyl)-5...)
Affinity DataIC50: 30.2nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732693((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-(trifluorometh...)
Affinity DataIC50: 30.2nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732676((R)-N-(1-(4-chlorophenyl)-2,2,2- trifluoroethyl)-5...)
Affinity DataIC50: 30.2nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732563((R)-5-Cyano-N-ethyl-N-(2,2,2-trifluoro-1-(p- tolyl...)
Affinity DataIC50: 30.9nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732691((R)—N-methyl-N-(2,2,2-trifluoro-1-(4-(trifluoromet...)
Affinity DataIC50: 31.6nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732592((R)-N-Ethyl-N-(2,2,2-trifluoro-1-(4- fluorophenyl)...)
Affinity DataIC50: 31.6nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732483(5-cyano-N-ethyl-N-(2,2,2-trifluoro-1-(4-fluorophen...)
Affinity DataIC50: 32.4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732633((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-fluorophenyl)e...)
Affinity DataIC50: 33.9nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732525((R)-5-cyano-N-methyl-N-(2,2,2-trifluoro-1- (4-(tri...)
Affinity DataIC50: 35.5nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732698(N-(1-(4-chlorophenyl)-2,2,2-trifluoroethyl-1-d)-5-...)
Affinity DataIC50: 35.5nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732694((R)—N-methyl-N-(2,2,2-trifluoro-1-(4-(trifluoromet...)
Affinity DataIC50: 36.3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732511(N-(1-(4-chlorophenyl)-2,2,2-trifluoroethyl)-5-cyan...)
Affinity DataIC50: 37.2nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732642((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-fluorophenyl)e...)
Affinity DataIC50: 38nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732606((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-fluorophenyl)e...)
Affinity DataIC50: 39.8nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732721((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-fluorophenyl)e...)
Affinity DataIC50: 39.8nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732523((R)-5-Cyano-N-(2-fluoroethyl)-N-(2,2,2- trifluoro-...)
Affinity DataIC50: 40.7nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732710((R)-N-(1-(3-chloro-4-fluorophenyl)-2,2,2- trifluor...)
Affinity DataIC50: 46.8nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732692((R)—N-methyl-N-(2,2,2-trifluoro-1-(4-(trifluoromet...)
Affinity DataIC50: 46.8nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732702((R)-5-cyano-N-ethyl-N-(2,2,2-trifluoro-1-(4- fluor...)
Affinity DataIC50: 49nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732695((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-(trifluorometh...)
Affinity DataIC50: 50.1nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732672((R)-N-ethyl-N-(2,2,2-trifluoro-1-(4- (trifluoromet...)
Affinity DataIC50: 51.3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732561(5-Cyano-N-ethyl-N-(2,2,2-trifluoro-1-(p- tolyl)eth...)
Affinity DataIC50: 57.5nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732628((R)—N-methyl-N-(2,2,2-trifluoro-1-(4-(trifluoromet...)
Affinity DataIC50: 58.9nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732589((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-fluorophenyl)e...)
Affinity DataIC50: 63.1nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732707((R)—N-(1-(3-chlorophenyl)-2,2,2-trifluoroethyl)-5-...)
Affinity DataIC50: 66.1nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732667((R)-N-methyl-N-(2,2,2-trifluoro-1-(4- (trifluorome...)
Affinity DataIC50: 67.6nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732671((R)—N-methyl-N-(2,2,2-trifluoro-1-(4-(trifluoromet...)
Affinity DataIC50: 70.8nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732517((R)-N-ethyl-N-(2,2,2-trifluoro-1-(4- fluorophenyl)...)
Affinity DataIC50: 72.4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732706((R)-5-cyano-N-(1-(3,4-difluorophenyl)-2,2,2- trifl...)
Affinity DataIC50: 72.4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732593((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-fluorophenyl)e...)
Affinity DataIC50: 72.4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732567(5-Cyano-N-ethyl-N-(2,2,2-trifluoro-1-(3- fluorophe...)
Affinity DataIC50: 77.6nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732723((R)—N-methyl-N-(2,2,2-trifluoro-1-(4-(trifluoromet...)
Affinity DataIC50: 81.3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732576((R)-5-Cyano-N-ethyl-N-(2,2,2-trifluoro-1-(4- (trif...)
Affinity DataIC50: 87.1nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732632((R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-fluorophenyl)e...)
Affinity DataIC50: 91.2nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732509((R)-5-(N-ethyl-N-(2,2,2-trifluoro-1-(4- fluorophen...)
Affinity DataIC50: 95.5nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732534((R)-N-ethyl-2-methyl-N-(2,2,2-trifluoro-1-(4- fluo...)
Affinity DataIC50: 97.7nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732518(N-ethyl-N-(2,2,2-trifluoro-1-(4- fluorophenyl)ethy...)
Affinity DataIC50: 97.7nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732686((R)—N-(1-(4-chlorophenyl)-2,2,2-trifluoroethyl)-N-...)
Affinity DataIC50: 100nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732730((R)-5-Cyano-N-methyl-N-(2,2,2-trifluoro-1- (4-fluo...)
Affinity DataIC50: 100nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 273 total ) | Next | Last >>
Jump to: